In accordance, the biological HSI > 36, reflecting NAFLD, was observed in 43.1% of patients (22/51; Fig 3B) and leptin, produced by fat cells, was increased in blood of patients with obesity (p = 0.012; Fig 3B). The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.